Atopix Therapeutics, Ltd. clinical trials
Acquired by Chiesi Farmaceutici S.p.A.
The registry lists 3 studies whose lead sponsor is Atopix Therapeutics, Ltd.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 26, 2018.
Registry sponsor names on this page
- Atopix Therapeutics, Ltd.3 studies
Something wrong with this grouping? Tell us on the Chiesi Farmaceutici S.p.A. page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All Chiesi Farmaceutici S.p.A. studies →
- Effect of OC000459 on Moderate to Severe Atopic DermatitisCompletedNCT02002208Phase 2
Sponsor listed in the registry: Atopix Therapeutics, Ltd. · Atopix Therapeutics, Ltd. — acquired company within the Chiesi Farmaceutici S.p.A. group
- First in Man Evaluation of Single and Multiple Doses of Oral ATX2417CompletedNCT02316912Phase 1
Sponsor listed in the registry: Atopix Therapeutics, Ltd. · Atopix Therapeutics, Ltd. — acquired company within the Chiesi Farmaceutici S.p.A. group
- Evaluation of Metabolic Profile of OC000459CompletedNCT02341521Phase 1
Sponsor listed in the registry: Atopix Therapeutics, Ltd. · Atopix Therapeutics, Ltd. — acquired company within the Chiesi Farmaceutici S.p.A. group